Literature DB >> 2989191

Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa.

R J Biggar, B K Johnson, C Oster, P S Sarin, D Ocheng, P Tukei, H Nsanze, S Alexander, A J Bodner, T A Siongok.   

Abstract

The prevalence of antibodies against HTLV-III and -I was studied among populations of 6 distinctly different regions of Kenya, an equatorial African country in which AIDS has rarely been observed. Overall, 21% of subjects had ELISA reactions suggesting the presence of antibody against HTLV-III. The frequency of HTLV-III antibodies was highest among the Turkana people (50%) and lowest among the Masai (8%). Prevalence increased with age but was not related to sex. The pattern of ELISA-detected antibody against HTLV-I was similar. The specificity of these antibodies was supported by Western blot analysis of a subset of sera with high and low ELISA ratios, in which 66% and 73% of those with ELISA ratios considered positive (= greater than 5.0 in this study) also had a profile of bands consistent with HTLV-III and HTLV-I respectively. The antibodies detected were not cross-reactive between HTLV-III and HTLV-I on Western blot analysis. In a series of subjects with various parasitic and infectious diseases, patients with idiopathic splenomegaly and with schistosomiasis had a high proportion of antibodies against both HTLV-III and HTLV-I. This survey shows that reactivity in the ELISA HTLV-III and HTLV-I assays are common among Kenyans but vary considerably by region.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Age Factors; Bacterial And Fungal Diseases; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Ethnic Groups; Geographic Factors; Hiv Infections; Infections; Kenya; Measurement; Parasitic Diseases; Population; Population Characteristics; Prevalence; Research Methodology; Sex Factors; Spatial Distribution; Tribes; Viral Diseases

Mesh:

Substances:

Year:  1985        PMID: 2989191     DOI: 10.1002/ijc.2910350611

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Seroepidemiology of human immunodeficiency virus in Africa.

Authors:  I Wendler; J Schneider; B Gras; A F Fleming; G Hunsmann; H Schmitz
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

Review 2.  A review of HIV-1 in Africa.

Authors:  A R Ronald; J O Ndinya-Achola; F A Plummer; J N Simonsen; D W Cameron; E N Ngugi; H Pamba
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

3.  Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.

Authors:  S L Tarsis; M T Yu; E S Parks; D Persaud; J L Muñoz; W P Parks
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution.

Authors:  K Kayembe; P Goubau; J Desmyter; R Vlietinck; H Carton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

5.  Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni.

Authors:  J Khalife; J M Grzych; R Pierce; J C Ameisen; A M Schacht; H Gras-Masse; A Tartar; J P Lecocq; A Capron
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

6.  Refining the global spatial limits of dengue virus transmission by evidence-based consensus.

Authors:  Oliver J Brady; Peter W Gething; Samir Bhatt; Jane P Messina; John S Brownstein; Anne G Hoen; Catherine L Moyes; Andrew W Farlow; Thomas W Scott; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2012-08-07

7.  Population-based Seroprevalence of HTLV-I Infection in Golestan Province, South East of Caspian Sea, Iran.

Authors:  Khodaberdi Kalavi; Abdolvahab Moradi; Alijan Tabarraei
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.